Avandia, the controversial diabetes drug introduced by GlaxoSmithKline in 1999, will no longer be available in retail pharmacies after this November. The FDA announced in September that it would take this action after a study showed Avandia was associated with increased cardiovascular risks. New rules governing the distribution and prescription of Avandia are now being…
↧